Tag: cancer
-
Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-
T-Cell Biotech Gains €17.5M in Grant, Equity Funds
A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency.
-
HPV Vaccine Generates Immune Responses in Trial
Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions.
-
Post-Surgical Fluid Cancer Analytics Company Gains $8M
A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds.
-
A.I. Shown to Enhance Diagnostics in Liquid Biopsies
A new analysis shows machine learning algorithms can provide more diagnostic details in liquid biopsies, blood tests to detect and track solid tumor cancers.
-
Trial Testing VR to Relieve Cancer Patient Distress
A clinical trial is underway assessing virtual reality interventions for relieving distress and improve the quality of life for cancer patients receiving bone marrow transplants.
-
Business-Academic Team to Create RNA Delivery for Cancer
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles.
-
Biotech Drug Shown to Kill Prostate Tumor Cells
Tests with lab mice show low doses of an experimental oral drug can selectively kill prostate cancer cells while not affecting surrounding healthy tissue.
-
AI-Aided Mobile App Shown to Screen for Melanoma
The developer of an app using algorithms to analyze images of skin lesions says clinical trial findings show the system detects melanoma more reliably than some physicians.
-
Collaboration Developing Microbiome Boost to Cancer Immunotherapy
A biotechnology company creating treatments that work with gut microbes is partnering with M.D. Anderson Cancer Center on more effective cancer immunotherapies.